Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

EMA Recommends Extension of Indications for Ponatinib Associated with a New Pharmaceutical Form and a New Strength
Дата публикации: 07-08-2026 07:08:00

New indication concerns a monotherapy in paediatric patients with CP-CML who are resistant or intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate or who have the T315I mutation

Основное содержимое страницы с новостью.

Subscribe to ESMO newsletter

Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH

© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1EMA Recommends Extension of Therapeutic Indications for Cetuximab011.314-08-2026
2EMA Recommends Extension of Therapeutic Indications for Epcoritamab08.0424-07-2026
3EMA Recommends Extension of Therapeutic Indications for Serplulimab013.8831-07-2026
4No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy with Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma011.2613-08-2026
5Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in First-Line Treatment of dMMR/MSI-H mCRC016.811-08-2026
6Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia05.6312-08-2026
7Immunoterapia: così cambia la pratica clinica nei carcinomi di polmone e vescica5729-06-2026
8В ОМС включат молекулярные исследования для диагностики рака у детей0012-02-2020
9New study reveals how blood cancers outsmart BTK-targeted therapies08.128-07-2026
10FDA approves Retevmo for RET fusion-positive solid tumors011.1616-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.64. Источник: www.esmo.org.